You have 9 free searches left this month | for more free features.

Newly Diagnosed Immune Thrombocytopenia

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Immune Thrombocytopenia Trial in Bristol (Mycophenolate Mofetil, Prednisolone)

Completed
  • Immune Thrombocytopenia
  • Bristol, United Kingdom
    University Hospital Bristol NHS Foundation Trust
Oct 25, 2022

Immune Thrombocytopenia Trial in Beijing (Baricitinib 2 MG, Dexamethasone)

Recruiting
  • Immune Thrombocytopenia
  • Beijing, China
  • +9 more
Jul 11, 2023

ITP - Immune Thrombocytopenia Trial (hetrombopag 5mg po qd, High-dose Dexamethasone)

Not yet recruiting
  • ITP - Immune Thrombocytopenia
  • hetrombopag 5mg po qd
  • High-dose Dexamethasone
  • (no location specified)
Jul 5, 2023

Immune Thrombocytopenia Trial in Beijing (Cyclosporine Oral Product, Prednisone)

Not yet recruiting
  • Immune Thrombocytopenia
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Jul 14, 2022

Thrombocytopenia Trial (Chidamide, HD-DXM)

Not yet recruiting
  • Thrombocytopenia
  • (no location specified)
Jun 6, 2022

Immune Thrombocytopenia Trial in United States (Eltrombopag, Steroids, IVIG)

Recruiting
  • Immune Thrombocytopenia
  • Birmingham, Alabama
  • +26 more
Dec 12, 2022

Primary Immune Thrombocytopenia Trial in Spain (Romiplostim plus dexamethasone, Dexamethasone)

Recruiting
  • Primary Immune Thrombocytopenia
  • Barcelona, Spain
  • +14 more
Dec 22, 2022

Immune Thrombocytopenia (ITP) Trial in Germany (Eltrombopag, Dexamethasone)

Recruiting
  • Immune Thrombocytopenia (ITP)
  • Mannheim, Baden-Wuerttemberg, Germany
  • +24 more
Dec 19, 2022

Primary Immune Thrombocytopenia (ITP) Trial in Switzerland (Eltrombopag (Revolade®), standard therapy (without eltrombopag):

Recruiting
  • Primary Immune Thrombocytopenia (ITP)
  • Eltrombopag (Revolade®)
  • standard therapy (without eltrombopag): HD-DXM
  • Aarau, Switzerland
  • +5 more
Sep 5, 2022

Immune Thrombocytopenia, Purpura, Thrombocytopenic Trial in Jinan (Atorvastatin 20mg, Atorvastatin 10mg, Dexamethasone)

Not yet recruiting
  • Immune Thrombocytopenia
  • Purpura, Thrombocytopenic
  • Atorvastatin 20mg
  • +2 more
  • Jinan, Shandong, China
    Qilu hospital, Shandong University
Aug 30, 2021

Primary Immune Thrombocytopenia Trial (2.5mg/d Hetrombopag)

Not yet recruiting
  • Primary Immune Thrombocytopenia
  • 2.5mg/d Hetrombopag
  • (no location specified)
Mar 28, 2022

ITP, Immune Thrombocytopenia Trial in Beijing (Dexamethasone, Tacrolimus)

Recruiting
  • ITP
  • Immune Thrombocytopenia
  • Beijing, China
    Peking University People's Hospital
Feb 5, 2021

Immune Thrombocytopenia Trial in Beijing (Dexamethasone, Acetylcysteine)

Unknown status
  • Immune Thrombocytopenia
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Apr 28, 2020

Glioblastoma, Gliosarcoma, Malignant Glioma Trial run by the NCI (TMZ, ipilimumab 3mg/kg, Nivolumab)

Recruiting
  • Glioblastoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 31, 2023

Newly Diagnosed Glioblastoma Trial (Pembrolizumab)

Not yet recruiting
  • Newly Diagnosed Glioblastoma
  • (no location specified)
Feb 22, 2022

Glioma, Malignant Trial in United States (biological, drug, radiation, other)

Active, not recruiting
  • Glioma, Malignant
  • AdV-tk
  • +5 more
  • Los Angeles, California
  • +7 more
Jan 30, 2023

Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arteritis

Recruiting
  • Polymyalgia Rheumatica (PMR)
  • Giant Cell Arteritis (GCA)
  • Data collection for cellular analyses (Immune subset composition, GCR expression, in vitro steroid responsiveness)
  • +3 more
  • Basel, Switzerland
    Department of Rheumatology University Hospital Basel
Aug 2, 2022

Glioblastoma Trial in Saint Louis (NeoVax, Nivolumab, Ipilimumab)

Terminated
  • Glioblastoma
  • NeoVax
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 26, 2021

Inflammatory and Immune Profiling of Kidney Tissue Obtained From

Completed
  • Proteinuria
  • +2 more
    • New York, New York
      The Rogosin Institute
    Feb 28, 2022

    Immune Thrombocytopenic Purpura Trial in Valhalla (rituxan)

    Recruiting
    • Immune Thrombocytopenic Purpura
    • Valhalla, New York
      New York Medical College
    Aug 4, 2021

    Small Cell Lung Cancer, Immunotherapy Trial in Changsha (chronic psychological stress)

    Recruiting
    • Small Cell Lung Cancer
    • Immunotherapy
    • chronic psychological stress
    • Changsha, Hunan, China
      Department of Oncology, The Second Xiangya Hospital, Central Sou
    Jul 22, 2023

    Lung Cancer, Chronic Stress Disorder, Immune Checkpoint Inhibitors Trial in Changsha (Gut microbiota detection, Peripheral

    Recruiting
    • Lung Cancer
    • +2 more
    • Gut microbiota detection
    • Peripheral immune cells signature detaction
    • Changsha, Hunan, China
      Department of Oncology, The Second Xiangya Hospital, Central Sou
    Jul 26, 2022

    Diabetes Type 1 and Fitness.

    Recruiting
    • Diabetes Mellitus
      • Poznan, Poland
        Department of Internal Medicine and Diabetiology Poznan Universi
      Jul 7, 2021

      Immune Thrombocytopenia Trial (VIT D)

      Not yet recruiting
      • Immune Thrombocytopenia
      • VIT D
      • (no location specified)
      Oct 5, 2023

      Severe Aplastic Anemia Trial in Boston, Salt Lake City (drug, procedure, radiation)

      Recruiting
      • Severe Aplastic Anemia
      • Boston, Massachusetts
      • +1 more
      Jan 13, 2023